Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

90.00 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Boston Scientific to Acquire Silk Road Medical in $1.16 billion USD Merger and Acquisition (M&A) Deal
Via AB Newswire
Unveiling 21 Analyst Insights On Boston Scientific
Via Benzinga
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal
Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024. 
Via Benzinga
Why Is Silk Road Medical (SILK) Stock Up 24% Today?
Silk Road Medical stock is up on Tuesday after Boston Scientific announced its acquiring the company in a $1.26 billion deal. 
Via InvestorPlace
Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover
The deal focuses on the company's stroke prevention product for patients with carotid artery disease. 
Via Investor's Business Daily
Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
From Silk Road Medical
Via GlobeNewswire
Check Out What Whales Are Doing With BSX
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
Via Benzinga
Jim Cramer Recommends Buying This Sports Betting Company's Stock: 'I Think It's Terrific'
Sports betting app DraftKings is "terrific," Cramer says. The company recently reported Q1 revenue of $1.18 billion, up 53% year-over-year. 
Via Benzinga
Decoding 18 Analyst Evaluations For Boston Scientific
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
Exposures US Equities
Boston Scientific's Upside With Cardiology Devices Drives Momentum
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
MarketBeat Week in Review – 4/29 - 5/3
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Citi Just Raised Its Price Target on These 3 Stocks
Discover the three stocks enjoying boosted Citi price targets. Analysts believe they are primed for success, so it's time to start buying. 
Via InvestorPlace
(BSX) - Analyzing Boston Scientific's Short Interest
Via Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
Needham Just Boosted Its Price Target on These 3 Stocks
Amidst the uncertainty in the market at this time, it is best to rely on Needham price targets to make informed decisions. 
Via InvestorPlace
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
Top 4 Health Care Stocks That May Plunge This Month
Via Benzinga
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy
Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm. 
Via Investor's Business Daily
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.